Singapore markets open in 4 hours 48 minutes
Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,267.84 -39.17 (-0.74%) Dow
39,065.26 -605.78 (-1.53%) Nasdaq
16,736.03 -65.51 (-0.39%) Bitcoin USD
66,822.48 -2,981.39 (-4.27%) CMC Crypto 200
1,460.86 -41.80 (-2.78%)
Oncotelic Therapeutics, Inc. (OTLC)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:28PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 14.63M |
| Enterprise value | 27.33M |
| Trailing P/E | 2.38 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 208.06 |
| Price/book (mrq) | 1.24 |
| Enterprise value/revenue | 390.48 |
| Enterprise value/EBITDA | 2.66 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 0.00% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 0.0500 |
| 52-week low 3 | 0.0100 |
| 50-day moving average 3 | 0.0398 |
| 200-day moving average 3 | 0.0364 |
Share statistics
| Avg vol (3-month) 3 | 64.82k |
| Avg vol (10-day) 3 | 85.42k |
| Shares outstanding 5 | 399.68M |
| Implied shares outstanding 6 | 412.13M |
| Float 8 | 180.54M |
| % held by insiders 1 | 54.83% |
| % held by institutions 1 | 0.00% |
| Shares short (15 Nov 2016) 4 | 662.75k |
| Short ratio (15 Nov 2016) 4 | 8.04 |
| Short % of float (15 Nov 2016) 4 | 2.50% |
| Short % of shares outstanding (15 Nov 2016) 4 | 2.50% |
| Shares short (prior month 14 Oct 2016) 4 | 812.77k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:12 |
| Last split date 3 | 28 Dec 2012 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -668.54% |
Management effectiveness
| Return on assets (ttm) | -0.89% |
| Return on equity (ttm) | -54.38% |
Income statement
| Revenue (ttm) | 70k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -7.79M |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 188.99k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 12.89M |
| Total debt/equity (mrq) | 114.62% |
| Current ratio (mrq) | 0.01 |
| Book value per share (mrq) | 0.03 |
Cash flow statement
| Operating cash flow (ttm) | -1.3M |
| Levered free cash flow (ttm) | -577.46k |
© 2024 Yahoo. All rights reserved.